Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials

被引：0
|
作者：
Reich, Kristian [1 ]
Langley, Richard G. [2 ]
Silvestre, Juan Francisco [3 ]
Staumont-Salle, Delphine [4 ]
Costanzo, Antonio [5 ]
Pink, Andrew [6 ]
Paller, Amy [7 ]
Katoh, Norito [8 ]
Wollenberg, Andreas [9 ]
Warren, Richard B. [10 ]
Oland, Christian Bjerregard [11 ]
Tindberg, Ann-Marie [11 ]
Gjerum, Le [11 ]
Simpson, Eric [12 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Gen Univ Dr Balmis, ISABIAL, Alicante, Brazil
[4] Univ Lille, Lille, France
[5] Humanitas Univ, Milan, Italy
[6] Guys & St Thomas Hosp, St Johns Inst Dermatol, London, England
[7] Northwestern Univ, Chicago, IL USA
[8] Kyoto Prefectural Univ Med, Kyoto, Japan
[9] Ludwig Maximilian Univ Munich, Munich, Germany
[10] Univ Manchester, Manchester, England
[11] LEO Pharma AS, Ballerup, Denmark
[12] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
atopic dermatitis; tralokinumab; IL-13; safety;
D O I：
10.1093/bjd/ljae266.028
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
649
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Safety Profile of Ixekizumab for the Treatment of Psoriatic Arthritis and Axial Spondyloarthritis up to 3 Years: An Updated Integrated Safety Analysis
    Schwartzman, Sergio
    Deodhar, Atul
    Combe, Bernard
    Accioly, Ana
    Kronbergs, Andris
    Janos, Boris
    Zhu, Danting
    Calderon, David Sandoval
    Rahman, Proton
    Poddubnyy, Denis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3820 - 3823
  • [42] SAFETY PROFILE OF IXEKIZUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS UP TO 3 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Tay, Tien
    Schwartzman, Sergio
    Deodhar, Atul
    Combe, Bernard
    Accioly, Ana
    Kronbergs, Andris
    Janos, Boris
    Zhu, Danting
    Sandoval, David
    Rahman, Proton
    Poddubnyy, Denis
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 42 - 42
  • [43] O09 Safety profile of baricitinib for the treatment of RA up to 8.4 years: an updated integrated safety analysis
    Winthrop, Kevin L.
    Takeuchi, Tsutomu
    Burmester, Gerd
    Deberdt, Walter
    Schlichting, Douglas
    Mo, Daojun
    Walls, Chad
    Smolen, Josef S.
    RHEUMATOLOGY, 2021, 60
  • [44] Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials
    Lu, Li-Chin
    Chao, Chien-Ming
    Chang, Shen-Peng
    Lan, Shao-Huan
    Lai, Chih-Cheng
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (12) : 1471 - 1478
  • [45] Conjunctivitis in Adult Patients with Tralokinumab for the Treatment of moderate to severe Atopic Dermatitis: Pooled Results from five Clinical Studies
    Wollenberg, A.
    Beck, L. A.
    Weller, de Bruin M.
    Zachariae, R.
    Olsen, C. K.
    Thyssen, J. P.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 63 - 63
  • [46] Synbiotics for Prevention and Treatment of Atopic Dermatitis A Meta-analysis of Randomized Clinical Trials
    Chang, Yung-Sen
    Trivedi, Michelle K.
    Jha, Ayan
    Lin, Yen-Feng
    Dimaano, Liezeel
    Garcia-Romero, Maria T.
    JAMA PEDIATRICS, 2016, 170 (03) : 236 - 242
  • [47] Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Meher, Bikash Ranjan
    Mohanty, Rashmi Ranjan
    Padhy, Biswa Mohan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2335 - 2343
  • [48] Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials
    Paller, Amy S.
    Ladizinski, Barry
    Mendes-Bastos, Pedro
    Siegfried, Elaine
    Soong, Weily
    Prajapati, Vimal H.
    Lio, Peter
    Thyssen, Jacob P.
    Simpson, Eric L.
    Platt, Andrew M.
    Raymundo, Eliza M.
    Liu, Jianzhong
    Calimlim, Brian M.
    Huang, Xiaohong
    Gu, Yihua
    Hu, Xiaofei
    Yang, Yang
    Su, John C.
    Zheng, Min
    Yamamoto-Hanada, Kiwako
    Teixeira, Henrique D.
    Irvine, Alan D.
    JAMA DERMATOLOGY, 2023, 159 (05) : 526 - 535
  • [49] Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis
    Lee, Joohee
    Seto, David
    Bielory, Leonard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (01) : 116 - 121
  • [50] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Zeng, Linxi
    Feng, Sen
    Yao, Lulu
    Wang, Bin
    Zhang, Guoqiang
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 734 - 740
12345